| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |